Abbott Laboratories (ABT)
117.71
+0.06
(+0.05%)
USD |
NYSE |
Nov 05, 16:00
117.71
0.00 (0.00%)
After-Hours: 16:18
Abbott Laboratories Cash from Operations (Quarterly): 2.705B for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.705B |
| June 30, 2024 | 1.96B |
| March 31, 2024 | 1.025B |
| December 31, 2023 | 3.038B |
| September 30, 2023 | 1.877B |
| June 30, 2023 | 1.203B |
| March 31, 2023 | 1.143B |
| December 31, 2022 | 2.326B |
| September 30, 2022 | 2.78B |
| June 30, 2022 | 2.41B |
| March 31, 2022 | 2.065B |
| December 31, 2021 | 3.067B |
| September 30, 2021 | 2.701B |
| June 30, 2021 | 2.128B |
| March 31, 2021 | 2.637B |
| December 31, 2020 | 3.798B |
| September 30, 2020 | 2.066B |
| June 30, 2020 | 1.322B |
| March 31, 2020 | 715.00M |
| December 31, 2019 | 2.416B |
| September 30, 2019 | 1.948B |
| June 30, 2019 | 1.06B |
| March 31, 2019 | 712.00M |
| December 31, 2018 | 1.765B |
| September 30, 2018 | 2.183B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.244B |
| March 31, 2018 | 1.108B |
| December 31, 2017 | 1.64B |
| September 30, 2017 | 2.005B |
| June 30, 2017 | 1.351B |
| March 31, 2017 | 574.00M |
| December 31, 2016 | 1.17B |
| September 30, 2016 | 1.217B |
| June 30, 2016 | 909.00M |
| March 31, 2016 | -93.00M |
| December 31, 2015 | 828.00M |
| September 30, 2015 | 1.195B |
| June 30, 2015 | 941.00M |
| March 31, 2015 | 2.00M |
| December 31, 2014 | 1.238B |
| September 30, 2014 | 1.201B |
| June 30, 2014 | 900.00M |
| March 31, 2014 | 336.00M |
| December 31, 2013 | 1.625B |
| September 30, 2013 | 522.00M |
| June 30, 2013 | 717.00M |
| March 31, 2013 | 460.00M |
| December 31, 2012 | 1.503B |
| September 30, 2012 | 3.520B |
| June 30, 2012 | 2.067B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
715.00M
Minimum
Mar 2020
3.798B
Maximum
Dec 2020
2.169B
Average
2.227B
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp | 1.002B |
| Becton Dickinson & Co | 1.263B |
| ResMed Inc | 325.54M |
| Integra Lifesciences Holdings Corp | 40.40M |
| QuidelOrtho Corp | -97.90M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -594.00M |
| Cash from Financing (Quarterly) | -1.576B |
| Free Cash Flow | 6.486B |
| Free Cash Flow Per Share (Quarterly) | 1.230 |
| Free Cash Flow to Equity (Quarterly) | 1.924B |
| Free Cash Flow to Firm (Quarterly) | 2.192B |
| Free Cash Flow Yield | 3.15% |